DK0920448T3 - Trunkeret gliacellelinie-afledt neurotrof faktor - Google Patents

Trunkeret gliacellelinie-afledt neurotrof faktor

Info

Publication number
DK0920448T3
DK0920448T3 DK96931618T DK96931618T DK0920448T3 DK 0920448 T3 DK0920448 T3 DK 0920448T3 DK 96931618 T DK96931618 T DK 96931618T DK 96931618 T DK96931618 T DK 96931618T DK 0920448 T3 DK0920448 T3 DK 0920448T3
Authority
DK
Denmark
Prior art keywords
cell line
neurotrophic factor
derived neurotrophic
glial cell
truncated
Prior art date
Application number
DK96931618T
Other languages
Danish (da)
English (en)
Inventor
Shaw-Fen Sylvia Hu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0920448T3 publication Critical patent/DK0920448T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96931618T 1995-09-28 1996-09-16 Trunkeret gliacellelinie-afledt neurotrof faktor DK0920448T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/535,681 US6184200B1 (en) 1995-09-28 1995-09-28 Truncated glial cell line-derived neurotrophic factor

Publications (1)

Publication Number Publication Date
DK0920448T3 true DK0920448T3 (da) 2006-04-10

Family

ID=24135310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96931618T DK0920448T3 (da) 1995-09-28 1996-09-16 Trunkeret gliacellelinie-afledt neurotrof faktor

Country Status (24)

Country Link
US (5) US6184200B1 (cs)
EP (1) EP0920448B1 (cs)
JP (3) JP4153036B2 (cs)
KR (1) KR100334739B1 (cs)
CN (1) CN1283659C (cs)
AT (1) ATE314389T1 (cs)
AU (1) AU707528B2 (cs)
CA (1) CA2232749C (cs)
CZ (1) CZ297326B6 (cs)
DE (1) DE69635675T2 (cs)
DK (1) DK0920448T3 (cs)
EA (1) EA001204B1 (cs)
ES (1) ES2255713T3 (cs)
HU (1) HU226220B1 (cs)
IL (6) IL144018A0 (cs)
MX (1) MX9802278A (cs)
NO (1) NO322521B1 (cs)
NZ (1) NZ318697A (cs)
SI (1) SI0920448T1 (cs)
SK (1) SK288094B6 (cs)
TW (1) TW570926B (cs)
UA (1) UA66339C2 (cs)
WO (1) WO1997011964A1 (cs)
ZA (1) ZA968087B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184200B1 (en) * 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
US6677135B1 (en) 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
DE19816186A1 (de) * 1998-04-14 1999-10-21 Univ Muenchen L Maximilians GDNF-kodierende DNA, Teile davon und GDNF-Varianten
US20020055467A1 (en) * 1998-07-06 2002-05-09 Johansen Teit E. Novel neurotrophic factors
US6507788B1 (en) * 1999-02-25 2003-01-14 Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function
US6897061B1 (en) 2000-06-16 2005-05-24 Spinal Cord Society Transdifferentiation of glial cells
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
US8946151B2 (en) 2003-02-24 2015-02-03 Northern Bristol N.H.S. Trust Frenchay Hospital Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
US7245117B1 (en) 2004-11-01 2007-07-17 Cardiomems, Inc. Communicating with implanted wireless sensor
BRPI0415563A (pt) 2003-10-20 2007-01-02 Nsgene As método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
CN1897977A (zh) * 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
CA2577690C (en) 2004-08-19 2013-08-06 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
PL2054074T3 (pl) * 2006-08-04 2015-03-31 Prolong Pharmaceuticals Llc Zmodyfikowana erytropoetyna
WO2008100966A1 (en) * 2007-02-12 2008-08-21 The Research Foundation Of State University Of New York Gdnf-derived peptides
EP2142205B1 (en) 2007-05-01 2014-04-02 Biogen Idec MA Inc. Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow
US8446454B2 (en) * 2007-05-21 2013-05-21 Polycom, Inc. Dynamic adaption of a continuous presence videoconferencing layout based on video content
FI20070808A0 (fi) * 2007-10-25 2007-10-25 Mart Saarma GDNF:n silmukointivariantit ja niiden käytöt
UA112981C2 (uk) * 2011-04-11 2016-11-25 Елі Ліллі Енд Компані Варіант людського gdnf
WO2014152511A1 (en) 2013-03-15 2014-09-25 The Jackson Laboratory Methods for promoting wound healing and hair growth
RU2561050C2 (ru) * 2013-08-28 2015-08-20 Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН) Применение белка yb-1 и его фрагментов для изготовления лекарственных средств при лечении болезни альцгеймера
WO2018089702A1 (en) 2016-11-10 2018-05-17 Keros Therapeutics, Inc. Gdnf fusion polypeptides and methods of use thereof
CA3162011A1 (en) * 2019-12-19 2021-06-24 Rodolphe SORET Use of glial cell line-derived neurotrophic factor (gdnf) for the treatment of enteric neuropathies
TW202325850A (zh) 2021-11-29 2023-07-01 大陸商上海瑞宏迪醫藥有限公司 Aadc、gdnf多核苷酸及其用於治療帕金森病

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
DE3572982D1 (en) 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
WO1990006952A1 (fr) 1988-12-22 1990-06-28 Kirin-Amgen, Inc. Facteur de stimulation de colonies de granulocytes modifies chimiquement
JP2877509B2 (ja) 1989-05-19 1999-03-31 アムジエン・インコーポレーテツド メタロプロテイナーゼ阻害剤
US5229500A (en) 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
CA1332433C (en) 1989-09-29 1994-10-11 Robert L. Sutherland Ski structure and binding therefor
DK0423980T3 (da) 1989-10-16 2000-10-09 Amgen Inc Stamcellefaktor
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
WO1991010470A1 (en) 1990-01-08 1991-07-25 Brown University Research Foundation Devices and methods for enhanced delivery of active factors
US5202428A (en) 1990-06-20 1993-04-13 The Salk Institute For Biological Studies DNA encoding neurotropic growth factor
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
AU679167B2 (en) 1991-09-20 1997-06-26 Amgen, Inc. Glial derived neurotrophic factor
AU1443095A (en) 1993-12-22 1995-07-10 University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
FR2717824B1 (fr) 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US5733875A (en) * 1994-11-15 1998-03-31 Amgen Inc. Methods of using GDNF as a neuroprotective agent
US5739307A (en) 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
US6184200B1 (en) 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
US5731284A (en) * 1995-09-28 1998-03-24 Amgen Inc. Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US5929041A (en) * 1996-02-23 1999-07-27 Amgen Inc. Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
US5837681A (en) * 1996-02-23 1998-11-17 Amgen Inc. Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
US5741778A (en) * 1996-03-19 1998-04-21 Amgen Inc. Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product

Also Published As

Publication number Publication date
JP2010279360A (ja) 2010-12-16
HUP9802262A2 (hu) 1999-01-28
US20110251267A1 (en) 2011-10-13
HU226220B1 (hu) 2008-06-30
JPH11512709A (ja) 1999-11-02
DE69635675T2 (de) 2006-07-06
AU7074696A (en) 1997-04-17
ATE314389T1 (de) 2006-01-15
ES2255713T3 (es) 2006-07-01
UA66339C2 (uk) 2004-05-17
IL144018A0 (en) 2002-04-21
AU707528B2 (en) 1999-07-15
SI0920448T1 (sl) 2006-04-30
IL144488A (en) 2006-12-31
SK288094B6 (sk) 2013-07-02
EP0920448A1 (en) 1999-06-09
DE69635675D1 (de) 2006-02-02
JP4909843B2 (ja) 2012-04-04
IL123761A (en) 2005-12-18
HK1021823A1 (en) 2000-07-07
MX9802278A (es) 1998-08-30
KR19990063825A (ko) 1999-07-26
US6184200B1 (en) 2001-02-06
CA2232749A1 (en) 1997-04-03
EP0920448B1 (en) 2005-12-28
JP2008067699A (ja) 2008-03-27
US20040214776A1 (en) 2004-10-28
EA199800301A1 (ru) 1998-10-29
US7611865B2 (en) 2009-11-03
JP4153036B2 (ja) 2008-09-17
NO981430L (no) 1998-03-30
SK38998A3 (en) 1999-07-12
EA001204B1 (ru) 2000-12-25
JP5241037B2 (ja) 2013-07-17
IL218336A0 (en) 2012-04-30
IL123761A0 (en) 1998-10-30
US7390781B2 (en) 2008-06-24
ZA968087B (en) 1997-06-12
US20040254114A1 (en) 2004-12-16
NZ318697A (en) 1999-09-29
US20040127419A1 (en) 2004-07-01
HUP9802262A3 (en) 2001-01-29
NO322521B1 (no) 2006-10-16
IL144018A (en) 2012-04-30
CA2232749C (en) 2003-03-25
CZ297326B6 (cs) 2006-11-15
WO1997011964A1 (en) 1997-04-03
CN1197461A (zh) 1998-10-28
TW570926B (en) 2004-01-11
CN1283659C (zh) 2006-11-08
NO981430D0 (no) 1998-03-30
IL144488A0 (en) 2002-05-23
CZ88298A3 (cs) 1999-02-17
KR100334739B1 (ko) 2002-09-17

Similar Documents

Publication Publication Date Title
DK0920448T3 (da) Trunkeret gliacellelinie-afledt neurotrof faktor
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
IL148060A0 (en) Compositions and methods for improved cell culture
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
WO2002029083A3 (en) Industrial-scale serum-free production of recombinant proteins in mammalian cells
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
ATE437951T1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
BG101408A (bg) Аналози на кератиноцитния растежен фактор
DE69638077D1 (de) Bakterielle Produktion von Interferon-beta Polypeptiden
TR200000175T2 (tr) Endogenik gen aktivasyonu ile eritropoietinin hazırlanması.
HUP9902640A2 (hu) Gliasejtvonal-eredetű neurotróf faktor receptor
BRPI0410562A (pt) molécula recombinante e veìculo para expressão, liberação e purificação de polipeptìdeos alvo
DE69637709D1 (de) Durch elektroporation vermittelter molekulartransfer in intakten pflanzen
IL126221A0 (en) Scf analog compositions and methods
GB2322132B (en) Keratinocyte growth factor-2 products
DE69817180D1 (de) Zns neuroregenerative zusammensetzungen und deren verwendungen
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
ECSP972224A (es) Celulas inmortalizadas para cultivo de virus